“Vaccines Authorized For
Children 4 years and under:
Children 5–11 years old:
Teens 12–17 years old:
Everyone 18 years and older:
*Everyone ages 18 years and older should get a booster dose of either Pfizer-BioNTech or Moderna (mRNA COVID-19 vaccines) at least 2 months after receiving the Johnson & Johnson’s Janssen (J&J/Janssen) vaccine in most situations.
Widespread vaccination for COVID-19 is a critical tool to best protect everyone from COVID-19 and COVID-19 related complications.
Everyone ages 12 years and older should get a COVID-19 booster shot. Learn more about booster shots.”
With the potential of the need for “annual” vaccines, it is difficult to find impartial data.
Basically the effectiveness of boosters needs to be balanced against cost, prevention, and potential side effects. Anecdotal and emotional arguments tend to cherry-pick to support a point of view.
We are far enough along that data has to be available and could provide a set of impartial facts. All the questions about blood clots (stroke) heart problems , pregnancy etc. should be settled by facts. Of course we don’t know long term effects, but we know something.
By age group I assume the data should support the risks for adopting a blanket booster compared to the risks.
The over 18 was further broken out in vaccine priorities. This was because of risk.
Phase 1b: frontline essential workers; persons ages 75+.
Phase 1c: persons ages 65-74; persons ages 16-64 with high-risk conditions; essential workers not included in Phase 1b.
Phase 2: all people 16+
I really think raw data should analyzed by impartial professionals would help. The problem is finding impartial professionals. At least provide the same data even if separate interpretations exist,
Just a hope that CDC will release data and defend recommendations. Pediatric deaths from COVID just dropped 24%!
https://www.washingtonexaminer.com/n...rror?_amp=true
This will be an ongoing issue as long as data is a moving target, incomplete and conclusions reached based on an undisclosed criteria.
More light than darkness is needed. Boosters included.
Children 4 years and under:
- None
Children 5–11 years old:
- Pfizer-BioNTech
Teens 12–17 years old:
- Pfizer-BioNTech
Everyone 18 years and older:
- Pfizer-BioNTech
- Moderna
- Johnson & Johnson’s Janssen
*Everyone ages 18 years and older should get a booster dose of either Pfizer-BioNTech or Moderna (mRNA COVID-19 vaccines) at least 2 months after receiving the Johnson & Johnson’s Janssen (J&J/Janssen) vaccine in most situations.
Widespread vaccination for COVID-19 is a critical tool to best protect everyone from COVID-19 and COVID-19 related complications.
Everyone ages 12 years and older should get a COVID-19 booster shot. Learn more about booster shots.”
With the potential of the need for “annual” vaccines, it is difficult to find impartial data.
Basically the effectiveness of boosters needs to be balanced against cost, prevention, and potential side effects. Anecdotal and emotional arguments tend to cherry-pick to support a point of view.
We are far enough along that data has to be available and could provide a set of impartial facts. All the questions about blood clots (stroke) heart problems , pregnancy etc. should be settled by facts. Of course we don’t know long term effects, but we know something.
By age group I assume the data should support the risks for adopting a blanket booster compared to the risks.
The over 18 was further broken out in vaccine priorities. This was because of risk.
Phase 1b: frontline essential workers; persons ages 75+.
Phase 1c: persons ages 65-74; persons ages 16-64 with high-risk conditions; essential workers not included in Phase 1b.
Phase 2: all people 16+
I really think raw data should analyzed by impartial professionals would help. The problem is finding impartial professionals. At least provide the same data even if separate interpretations exist,
Just a hope that CDC will release data and defend recommendations. Pediatric deaths from COVID just dropped 24%!
https://www.washingtonexaminer.com/n...rror?_amp=true
This will be an ongoing issue as long as data is a moving target, incomplete and conclusions reached based on an undisclosed criteria.
More light than darkness is needed. Boosters included.
Comment